The DSM might be holding us back from developing better treatments. A new study attempts to uncover a more accurate ...
Hosted on MSN1mon
DSM-Firmenich stock rises on Q4 earnings beatInvesting.com -- Shares of DSM-Firmenich AG (SWX ... The Taste, Texture & Health (TTH) segment's Organic Sales Growth (OSG) of 4% in the fourth quarter was slightly below the consensus of 6% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback